tazobactam has been researched along with Burkholderia pseudomallei Infection in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Meesing, A; Sribenjalux, W; Wonglakorn, L | 1 |
Cronin, K; Engler, C; Norton, R; Parsonson, F; Slack, A | 1 |
Subaalaxmi, MV | 1 |
3 other study(ies) available for tazobactam and Burkholderia pseudomallei Infection
Article | Year |
---|---|
In vitro susceptibility of Burkholderia pseudomallei isolates from Thai patients to ceftolozane/tazobactam and ceftazidime/avibactam.
Topics: Azabicyclo Compounds; Burkholderia pseudomallei; Ceftazidime; Cephalosporins; Humans; Melioidosis; Pseudomonas aeruginosa; Tazobactam; Thailand | 2022 |
Activity of Ceftolozane-Tazobactam against
Topics: Anti-Bacterial Agents; Burkholderia pseudomallei; Cephalosporins; Cross Infection; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Humans; Melioidosis; Microbial Sensitivity Tests; Tazobactam | 2018 |
Septicemic melioidosis.
Topics: Humans; Male; Melioidosis; Penicillanic Acid; Piperacillin; Sepsis; Tazobactam; Time Factors; Treatment Outcome | 2010 |